Loading clinical trials...
Loading clinical trials...
Repetitive Transcranial Magnetic Stimulation Efficacy for Major Resistant Depression Compared or Associated With Venlafaxine : a Multicentric Study.
The purpose of this study is to assess the efficacy of add-on therapy with repetitive Transcranial Magnetic Stimulation (rTMS) and venlafaxine in the treatment of major depressive disorders compared to venlafaxine only (the optimal medication) and to rTMS only.
rTMS parameters : Intensity of 120% of individually determined motor threshold; frequency : 1 Hz; 360 impulsions; on period : 1 min; off period : 30 s.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte
Besançon, France
C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO
Bron, France
C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A
Clermont-Ferrand, France
Hôpital Louis Mourier
Colombes, France
C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie
Dijon, France
C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie
Grenoble, France
ASM Limoux
Lézignan-Corbières, France
Hôpital Fontan - C.H.R.U. Lille
Lille, France
C.H. Sainte Marguerite
Marseille, France
CHU - Hôpital La Colombière
Montpellier, France
Start Date
May 1, 2008
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2013
Last Updated
July 19, 2013
170
ACTUAL participants
active venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed
OTHER
active rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and sham venlafaxine
OTHER
sham rTMS- repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and active venlafaxine
OTHER
Lead Sponsor
Club rTMS et Psychiatrie
Collaborators
NCT07042217
NCT06371352
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05894980